Girard Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $228K | Sell |
1,662
-870
| -34% | -$119K | 0.02% | 243 |
|
2024
Q1 | $337K | Sell |
2,532
-512
| -17% | -$68.2K | 0.03% | 219 |
|
2023
Q4 | $420K | Sell |
3,044
-2,133
| -41% | -$294K | 0.04% | 196 |
|
2023
Q3 | $631K | Sell |
5,177
-2,339
| -31% | -$285K | 0.07% | 160 |
|
2023
Q2 | $1.06M | Sell |
7,516
-13,034
| -63% | -$1.83M | 0.11% | 137 |
|
2023
Q1 | $2.91M | Sell |
20,550
-4,557
| -18% | -$645K | 0.32% | 73 |
|
2022
Q4 | $3.93M | Sell |
25,107
-594
| -2% | -$92.9K | 0.45% | 57 |
|
2022
Q3 | $3.15M | Sell |
25,701
-1,503
| -6% | -$184K | 0.42% | 61 |
|
2022
Q2 | $3.62M | Sell |
27,204
-1,888
| -6% | -$251K | 0.46% | 61 |
|
2022
Q1 | $3.98M | Sell |
29,092
-11,185
| -28% | -$1.53M | 0.44% | 62 |
|
2021
Q4 | $6.97M | Sell |
40,277
-727
| -2% | -$126K | 0.76% | 39 |
|
2021
Q3 | $5.96M | Buy |
41,004
+406
| +1% | +$59K | 0.75% | 36 |
|
2021
Q2 | $5.36M | Buy |
40,598
+1,702
| +4% | +$225K | 0.69% | 41 |
|
2021
Q1 | $4.99M | Buy |
38,896
+1,796
| +5% | +$230K | 0.72% | 43 |
|
2020
Q4 | $4.42M | Buy |
37,100
+1,435
| +4% | +$171K | 0.68% | 47 |
|
2020
Q3 | $4.08M | Buy |
35,665
+6,665
| +23% | +$763K | 0.68% | 45 |
|
2020
Q2 | $3.3M | Sell |
29,000
-672
| -2% | -$76.6K | 0.6% | 47 |
|
2020
Q1 | $2.38M | Buy |
29,672
+2,883
| +11% | +$231K | 0.48% | 61 |
|
2019
Q4 | $2.86M | Buy |
26,789
+793
| +3% | +$84.7K | 0.47% | 63 |
|
2019
Q3 | $2.78M | Buy |
25,996
+703
| +3% | +$75.2K | 0.52% | 62 |
|
2019
Q2 | $2.58M | Buy |
25,293
+880
| +4% | +$89.6K | 0.45% | 67 |
|
2019
Q1 | $2.2M | Buy |
24,413
+8,812
| +56% | +$792K | 0.41% | 71 |
|
2018
Q4 | $1.3M | Buy |
15,601
+2,211
| +17% | +$184K | 0.27% | 88 |
|
2018
Q3 | $1.44M | Buy |
13,390
+4,300
| +47% | +$464K | 0.26% | 94 |
|
2018
Q2 | $999K | Buy |
+9,090
| New | +$999K | 0.19% | 121 |
|